618 related articles for article (PubMed ID: 16080648)
1. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
2. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
[TBL] [Abstract][Full Text] [Related]
4. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
5. Hereditary haemorrhagic telangiectasia: state of the art.
Fiorella ML; Ross DA; White RI; Sabbà C; Fiorella R
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):330-6. PubMed ID: 15952682
[TBL] [Abstract][Full Text] [Related]
6. Hereditary haemorrhagic telangiectasia.
Sharathkumar AA; Shapiro A
Haemophilia; 2008 Nov; 14(6):1269-80. PubMed ID: 19141168
[TBL] [Abstract][Full Text] [Related]
7. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
8. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous embolization for control of nasal blood circulation.
Parnes LS; Heeneman H; Vinuela F
Laryngoscope; 1987 Nov; 97(11):1312-5. PubMed ID: 2823032
[TBL] [Abstract][Full Text] [Related]
10. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
[TBL] [Abstract][Full Text] [Related]
11. [Current treatment of Rendu-Osler disease, excluding radiation].
Fleury P; Sauvage JP; Beutter P; Maylin C
Ann Otolaryngol Chir Cervicofac; 1976; 93(1-2):79-93. PubMed ID: 788614
[TBL] [Abstract][Full Text] [Related]
12. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) Management of epistaxis and oral hemorrhage by Nd-Yag laser].
Galletta A; Amato G
Minerva Stomatol; 1998 Jun; 47(6):283-6. PubMed ID: 9738363
[TBL] [Abstract][Full Text] [Related]
15. A natural obturator in hereditary haemorrhagic telangiectasia.
Soni-Jaiswal A; Woolford TJ
J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
[TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
Weissman JL; Jungreis CA; Johnson JT
Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
[TBL] [Abstract][Full Text] [Related]
18. [A new sclerosant for the treatment of Rendu-Osler-Weber disease].
Ramírez B; Morais D; Condado MA; Marcos M; Martín G; Poncela M
Acta Otorrinolaringol Esp; 2000; 51(1):36-9. PubMed ID: 10799930
[TBL] [Abstract][Full Text] [Related]
19. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
[TBL] [Abstract][Full Text] [Related]
20. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
